PharmaCyte Biotech Inc (PMCB)

[1234jklm]

Successful tests bring confidence in the company and technology

Each new announcement shows us the careful and methodical way pcmb are preparing their ind.

The recent ifosfamide results show how thorough their preparation is.

Not one poster on this board has ever raised the issue of whether the activating cells might be killed by the ifosfamide.

But the company is onto it.


How much is a tumor fighting focused treatment using existing chemotherapy worth when it has no side effects?

Expect vastly improved efficacy with more activating cells in each ciab cap and more doses and better imaging to read cell death.

This weeks successful Merck results show the value of immunotherapy with chemotherapy and the doubling of life expectancy it brought in lung cancer.

A focused targeted chemotherapy without side effects plus immunotherapy looks like an ideal combination therapy.

Tumor reduction with no side effects. How much is that worth when immunotherapy already costs 150,000usd?